Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Improvement in perioperative outcome after hepatic resection

The number of hepatic segments resected and operative blood loss are the only predictors of perioperative morbidity and mortality in hepatic resectional surgery, find researchers in the October issue of the Annals of Surgery.

News image

fiogf49gjkf04

The team from New York, USA, assessed the nature of changes in the field of hepatic resectional surgery and the impact of these changes on perioperative outcome.

The researchers examined data from 1803 consecutive patients undergoing hepatic resection at the Memorial Sloan-Kettering Cancer Center, New York, from 1991 to 2001.

Demographics, extent of resection, concomitant major procedures, operative and transfusion data, complications, and hospital stay were analyzed.

Factors associated with morbidity and mortality, and trends in operative and perioperative variables over the study period were also assessed.

The team found that malignant disease was the most common diagnosis (91%), with metastatic colorectal cancer accounting for 62% of these cases.

Also that, 375 resections (21%) were performed for primary hepatic or biliary cancers and 161 (9%) for benign disease.

Decrease in operative mortality from 4% to 1%.
Annals of Surgery
Anatomical resections were performed in 1568 patients (87%), these included 544 extended hepatectomies, 483 hepatectomies, and 526 segmental resections.

The team found that 62% of patients had three or more segments resected, 42% had bilobar resections, and 37% had concomitant additional major procedures.

It was discovered that the median blood loss was 600 ml and 49% of patients were transfused at any time during the index admission.

Median hospital stay was 8 days, morbidity was 45%, and operative mortality was 3.1%.

The research team identified a significant increase in the use of parenchymal-sparing segmental resections, as well as a decrease in the number of hepatic segments resected, during the study period.

In parallel with this, there was a significant decline in blood loss, the use of blood products, and hospital stay.

Furthermore, despite an increase in concomitant major procedures, operative mortality decreased from 4% in the first 5 years of the study, to 1% in the last 2 years. There were no operative deaths in the last 184 consecutive cases.

By using multivariate analysis, the team revealed that the number of hepatic segments resected and operative blood loss were the only independent predictors of both perioperative morbidity and mortality.

Dr William Jarnagin's team concluded that, "Over the past decade, the use of parenchymal-sparing segmental resections has increased significantly".

And that, "The number of hepatic segments resected and operative blood loss were the only predictors of both perioperative morbidity and mortality.

"Reductions in these are largely responsible for the decrease in perioperative mortality, which has occurred despite an increase in concomitant major procedures".

Ann Surg 2002; 236 (4): 397-407
10 October 2002

Go to top of page Email this page Email this page to a colleague

 23 November 2017 
Distance travelling for rectal cancer outcomes
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Pharmacological management of GERD
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us